hyperCORE International, a strategic scaling platform that helps clinical research sites and organizations grow through partnership, has announced the election of its officers. Jeffrey Smyth has been elected President, Seneca Harrison as Vice President, and Claxton Copeland as Secretary, while Dustin Owen will continue serving as Treasurer. The appointments support hyperCORE's refreshed focus on serving two distinct audiences through one platform: clinical research site networks and contract research organizations (CROs).
For site networks, hyperCORE accelerates growth while preserving independence. For CROs, it provides a single strategic connection to a growing network of experienced, high-performing research sites. The new officers bring complementary expertise and strategic leadership to guide hyperCORE's continued evolution, strengthen partnerships, and support sustainable growth across the organization. The leadership transition comes as hyperCORE sharpens its value proposition for both site networks and CROs, aiming to scale collective impact in clinical research.
Newly elected President Jeffrey Smyth expressed gratitude for the confidence of his fellow partners. "The camaraderie across our network is what makes this group special, and it positions us well for continued growth," Smyth said. "I step into this role with excitement as we scale our collective impact for CROs and patients." His comments underscore the collaborative model that hyperCORE leverages to expand its reach and effectiveness.
Nicholas Focil, former President, emphasized the organization's core purpose. "At hyperCORE, our purpose is simple. We help our partners scale," Focil said. "That means giving exceptional site networks the support to grow on their own terms, and giving CROs one trusted connection to the sites and patients their studies need. Strong leadership is essential to that mission, and we're pleased to welcome the new executive team." The election of officers is therefore not merely a procedural formality but a strategic move to ensure continuity and drive the platform's growth agenda.
hyperCORE's current class of partner site networks includes Empathx Clinical Research, FOMAT Medical Research, Optimal Research Sites, QCR Network, and TrueBlue Clinical Research. Its alumni include Lynd Clinical (formerly ARC), Avacare (formerly Benchmark Clinical Research), Flourish Research (formerly CSP & CTT), Centricity Research (formerly IACT Health, LMC Manna, Aventiv, and Lucas Research), and, most recently, Alcanza Clinical Research. This track record demonstrates hyperCORE's ability to help site networks scale while maintaining their independence.
For CROs, hyperCORE streamlines site access through a single point of contact, offering rapid feasibility with 48 to 72 hour turnaround, broader geographic reach across the United States, and expanded patient access. The network brings together more than 50 sites, 120+ principal investigators, and experience across more than 25 therapeutic areas and multiple trial phases, with access to more than 3.4 million patients. These metrics highlight the tangible benefits that the new leadership team will steward as hyperCORE continues to evolve. The election of Smyth, Harrison, Copeland, and Owen is a clear signal that hyperCORE International is positioning itself for sustained growth and deeper partnerships in the clinical research landscape.
